Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

342

Full text

271

Free full text

125

Publication Types

Journal Article

344

Clinical Trial, Phase II

148

Research Support, Non-U.S. Gov't

134

Clinical Trial

104

Multicenter Study

Randomized Controlled Trial

Clinical Trial, Phase I

Comparative Study

Clinical Trial, Phase III

Review

Research Support, N.I.H., Extramural

Case Reports

Observational Study

Meta-Analysis

Controlled Clinical Trial

Systematic Review

Research Support, U.S. Gov't, P.H.S.

Comment

Letter

Validation Study

Consensus Development Conference

Practice Guideline

Network Meta-Analysis

News

Clinical Trial Protocol

Equivalence Trial

Publication Year

From

Quick links

Individual year

2026

2024

2023

2022

2021

2020

2019

2018

2017

2016

2015

2014

2013

2012

2011

2010

2009

2008

2007

2006

2005

2004

2003

2002

2001

2000

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Tegafur""[mesh_terms]

347 Results

Searching titles within these results

Severe hypertriglyceridemia induced by S-1: Subsequent case series of four patients and further review of the literature.

Yoshitaka Saito, Yoh Takekuma, Satoshi Takeuchi, Yoshito Komatsu, Mitsuru Sugawara

International journal of clinical pharmacology and therapeutics 2021;59(12):787-793

Full Text

Abstract

Randomized phase II study of tegafur-uracil/leucovorin versus tegafur-uracil/leucovorin plus oxaliplatin after curative resection of high-risk stage II/III colorectal cancer (SOAC-1101 trial).

Chihiro Kosugi, Keiji Koda, Nobuhiro Takiguchi, Satoru Takaishi, Hideaki Miyauchi, Nobuo Hirayama, Yukihiro Nomura, Eisuke Kondo, Yohei Kawasaki, Yoshihito Ozawa, Hisahiro Matsubara

International journal of colorectal disease 2021;36(8):1739-1749

Full Text

Abstract

Mechanism of action of fluoropyrimidines: relevance to the new developments in colorectal cancer chemotherapy.

C Aschele, A Sobrero, A Guglielmi, F Grossi, F Puglisi

Seminars in oncology 2000;27(5 Suppl 10):72-7

Full Text

Adjuvant Chemotherapy With UFT/LV UFT/LV Plus PSK in Stage II/III Colorectal Cancer.

Hiroshi Saeki, Ken Shirabe, Hiroomi Ogawa, Takuya Shiraishi, Takuhisa Okada, Yohei Miyamae, Yoko Motegi

Anticancer research 2024;44(2):805-814

Full Text

Abstract

S-1 and oxaliplatin versus tegafur-uracil and leucovorin as post-operative adjuvant chemotherapy in patients with high-risk stage III colon cancer: updated 5-year survival of the phase III ACTS-CC 02 trial.

J Watanabe, S Sasaki, T Kusumoto, Y Sakamoto, K Yoshida, N Tomita, A Maeda, J Teshima, M Yokota, C Tanaka, J Yamauchi, H Uetake, M Itabashi, K Takahashi, H Baba, K Kotake, N Boku, K Aiba, S Morita, N Takenaka, K Sugihara

ESMO open 2021;6(2):100077

Free Full Text

Abstract

Clinical studies of three oral prodrugs of 5-fluorouracil (capecitabine, UFT, S-1): a review.

M Malet-Martino, R Martino

The oncologist 2002;7(4):288-323

Free Full Text

Abstract

A phase II trial of UFT and leucovorin in women 65 years and older with advanced breast cancer.

Supriya Gupta, Ann M Mauer, Christopher W Ryan, David A Taber, Brian L Samuels, Gini F Fleming

American journal of clinical oncology 2005;28(1):65-9

Full Text

Abstract

Other fluorinated pyrimidines in the treatment of solid tumors.

P M Hoff, E D Saad

Oncology (Williston Park, N.Y.) 2001;15(1 Suppl 2):65-8

Full Text

Abstract

Hypertriglyceridemia induced by S-1: A novel case report and review of the literature.

Yoh Takekuma, Yoshito Komatsu, Yoshitaka Saito, Mitsuru Sugawara

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 2021;27(4):1020-1025

Full Text

Abstract

Administration Method of Adjuvant Tegafur-Uracil and Leucovorin Calcium in Patients with Resected Colorectal Cancer: A Phase III Study.

Taishi Hata, Kiyotaka Hagihara, Anna Tsutsui, Hiroki Akamatsu, Masayuki Ohue, Tatsushi Shingai, Mitsuyoshi Tei, Masakazu Ikenaga, Ho Min Kim, Hideki Osawa, Hiroyoshi Takemoto, Ken Konishi, Mamoru Uemura, Chu Matsuda, Tsunekazu Mizushima, Kohei Murata, Yuko Ohno, Yuichiro Doki, Hidetoshi Eguchi

The oncologist 2021;26(5):e735-e741

Free Full Text

Abstract

Oral fluoropyrimidines in colorectal cancer.

E Van Cutsem, M Peeters

Seminars in oncology 2000;27(5 Suppl 10):91-5

Full Text

Phase I clinical and pharmacokinetic study of oral S-1 in patients with advanced solid tumors.

C J van Groeningen, G J Peters, J H Schornagel, H Gall, P Noordhuis, M J de Vries, S L Turner, M S Swart, H M Pinedo, A R Hanauske, G Giaccone

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(14):2772-9

Full Text

Abstract

Meta-analysis Exploring the Effectiveness of S-1-Based Chemotherapy for Advanced Non-Small Cell Lung Cancer.

Xin Sun, Li Sun, Shu-Ling Zhang, Zhi-Cheng Xiong, Jie-Tao Ma, Cheng-Bo Han

The Tohoku journal of experimental medicine 2017;241(1):1-11

Free Full Text

Abstract

Postgastrectomy pharmacokinetic changes of S-1 in patients with localized advanced gastric cancer.

Hyeong-Seok Lim, Keun Won Ryu, Jun Ho Lee, Young-Woo Kim, Il Ju Choi, Mi-Jung Kim, Young-Iee Park, Aekyung Hwang, Sook Ryun Park

Journal of clinical pharmacology 2016;55(8):926-35

Full Text

Abstract

UFT and oral leucovorin as radiation sensitizers in rectal and other gastrointestinal malignancies.

Paulo M Hoff, Everardo D Saad

Cancer investigation 2003;21(4):624-9

Full Text

Abstract

Results: 1 – 15 / 347

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Tegafur""[mesh_terms]

Severe hypertriglyceridemia induced by S-1: Subsequent case series of four patients and further review of the literature.

Randomized phase II study of tegafur-uracil/leucovorin versus tegafur-uracil/leucovorin plus oxaliplatin after curative resection of high-risk stage II/III colorectal cancer (SOAC-1101 trial).

Mechanism of action of fluoropyrimidines: relevance to the new developments in colorectal cancer chemotherapy.

Adjuvant Chemotherapy With UFT/LV UFT/LV Plus PSK in Stage II/III Colorectal Cancer.

S-1 and oxaliplatin versus tegafur-uracil and leucovorin as post-operative adjuvant chemotherapy in patients with high-risk stage III colon cancer: updated 5-year survival of the phase III ACTS-CC 02 trial.

Clinical studies of three oral prodrugs of 5-fluorouracil (capecitabine, UFT, S-1): a review.

A phase II trial of UFT and leucovorin in women 65 years and older with advanced breast cancer.

Other fluorinated pyrimidines in the treatment of solid tumors.

Hypertriglyceridemia induced by S-1: A novel case report and review of the literature.

Administration Method of Adjuvant Tegafur-Uracil and Leucovorin Calcium in Patients with Resected Colorectal Cancer: A Phase III Study.

Oral fluoropyrimidines in colorectal cancer.

Phase I clinical and pharmacokinetic study of oral S-1 in patients with advanced solid tumors.

Meta-analysis Exploring the Effectiveness of S-1-Based Chemotherapy for Advanced Non-Small Cell Lung Cancer.

Postgastrectomy pharmacokinetic changes of S-1 in patients with localized advanced gastric cancer.

UFT and oral leucovorin as radiation sensitizers in rectal and other gastrointestinal malignancies.

Results for
""Tegafur""[mesh_terms]